Literature DB >> 9630506

Regulation of immediate early gene c-fos and zif/268 mRNA expression in rat striatum by metabotropic glutamate receptor.

J Q Wang1.   

Abstract

Metabotropic glutamate receptors are coupled to multiple intracellular second messenger systems through G-proteins and densely expressed by medium spiny projection neurons in the rat striatum. In chronically-cannulated rats, this study demonstrated that pharmacological activation of metabotropic glutamate receptors by intrastriatal injection of a selective agonist, ACPD, elevated immediate early gene c-fos and zif/268 mRNA expression in the injected dorsal striatum as revealed by quantitative in situ hybridization. The elevation of both c-fos and zif/268 was dose-dependent and the responsiveness of c-fos to ACPD at each dose surveyed was greater than that of zif/268. Induction of the two mRNAs was rapid and transient as increases in the 2 mRNAs became evident as early as 30 min, reached a peak at 1 h, and returned to normal levels 3 (c-fos) or 6 (zif/268) h, after ACPD injection. Coadministration of the selective metabotropic glutamate receptor antagonist, MCPG, with ACPD markedly attenuated ACPD-stimulated c-fos, but not zif/268, expression. Pretreatment with the ionotropic NMDA receptor antagonist, CPP, had no effect on ACPD-stimulated c-fos expression, but partially attenuated ACPD-stimulated zif/268 expression. Blockade of D1 dopamine receptors with SCH-23390 did not alter the ability of ACPD to induce the expression of these genes. These data demonstrate a difference between the profound induction of c-fos and zif/268 gene expression in response to specific activation of metabotropic glutamate receptors in striatal neurons. Furthermore, c-fos induction was independent of D1 dopaminergic and NMDA glutamatergic transmission, whereas zif/268 induction was mediated, at least in part, by NMDA receptors. Copyright 1998 Elsevier Science B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630506     DOI: 10.1016/s0169-328x(98)00060-6

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  6 in total

1.  Effects of hypoxic preconditioning on expression of transcription factor NGFI-A in the rat brain after unavoidable stress in the "learned helplessness" model.

Authors:  K A Baranova; E A Rybnikova; V I Mironova; M O Samoilov
Journal:  Neurosci Behav Physiol       Date:  2010-06-11

2.  High- and low-frequency repetitive transcranial magnetic stimulation differentially activates c-Fos and zif268 protein expression in the rat brain.

Authors:  Selcen Aydin-Abidin; Jörn Trippe; Klaus Funke; Ulf T Eysel; Alia Benali
Journal:  Exp Brain Res       Date:  2008-04-02       Impact factor: 1.972

3.  Repeated cocaine administration increases nitric oxide efflux in the rat dorsal striatum.

Authors:  Dong Kun Lee; Wei Choon Alvin Koh; Yoon-Bo Shim; Insop Shim; Eun Sang Choe
Journal:  Psychopharmacology (Berl)       Date:  2009-11-20       Impact factor: 4.530

4.  Cocaine activates Homer1 immediate early gene transcription in the mesocorticolimbic circuit: differential regulation by dopamine and glutamate signaling.

Authors:  M Behnam Ghasemzadeh; Lindsay K Windham; Russell W Lake; Christopher J Acker; Peter W Kalivas
Journal:  Synapse       Date:  2009-01       Impact factor: 2.562

5.  Sequential cocaine-alcohol self-administration produces adaptations in rat nucleus accumbens core glutamate homeostasis that are distinct from those produced by cocaine self-administration alone.

Authors:  Bethany A Stennett; Yasmin Padovan-Hernandez; Lori A Knackstedt
Journal:  Neuropsychopharmacology       Date:  2019-07-02       Impact factor: 8.294

6.  Role of prefrontal cortex projections to the nucleus accumbens core in mediating the effects of ceftriaxone on cue-induced cocaine seeking.

Authors:  Allison R Bechard; Carly N Logan; Javier Mesa; Yasmin Padovan-Hernandez; Harrison Blount; Virginia L Hodges; Lori A Knackstedt
Journal:  Addict Biol       Date:  2020-06-18       Impact factor: 4.093

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.